Nachrichten zur Johnson & Johnson Aktie

Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol-Myers trades at a significant valuation discount, but its higher leverage and patent risks contrast sharply with Johnson & Johnsons…

Johnson & Johnson: 3 Key Takeaways for Long-Term Investors

MedTech growth stalled while pharma surged, leaving the company to bet on new product launches and a planned spin-off to…

Johnson & Johnson: 3 Key Takeaways for Long-Term Investors

MedTech growth stalled while pharma surged, leaving the company to bet on new product launches and a planned spin-off to…

Citi renews Johnson Matthey coverage with buy rating and £28.50 target price

Citi, the investment bank, has renewed its coverage of Johnson Matthey PLC (LSE:JMAT), the London-listed specialty chemicals group, with a…

Johnson & Johnson Aktie: Starkes drittes Quartal - doch 2027 droht Stagnation

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Bernstein:Die Analysten von Bernstein heben ihr Kursziel für die Aktie von Johnson…

JNJ Q3 Earnings Call Highlights Growth Outlook and MedTech Challenges

Johnson & Johnson raises its 2026 sales and earnings outlook as strong pharmaceutical growth offsets MedTech challenges, while 2027 dilution…

Johnson & Johnson: Keep Calm And Hold On

…

Johnson & Johnson (JNJ) Q3 2026 Earnings Call Transcript

…

Stock Market Midday, Oct. 13: Bank Earnings and Chip Pressure Drive Mixed Trading

Goldman Sachs gains on strong revenue while Johnson & Johnson stumbles on earnings miss, today, Oct. 13, 2026.…

ROUNDUP: Johnson & Johnson erhöht Prognose - Rückstellungen belasten

NEW BRUNSWICK (dpa-AFX) - Der US-Gesundheitskonzern Johnson & Johnson hat seine Gewinnprognose erneut erhöht.…

Johnson & Johnson erhöht Prognose - Rückstellungen für Rechtsvergleich belasten

NEW BRUNSWICK (dpa-AFX) - Der US-Gesundheitskonzern Johnson & Johnson hat seine Gewinnprognose erneut erhöht.…

J&J Medtech Sales Disappoint, Considers Orthopedic Spinoff

Johnson & Johnson reported a 2.5% rise in medical technology sales, missing estimates, and is leaning toward a spinoff of…

Johnson & Johnson beats estimates, raises 2026 guidance

Johnson & Johnson beats estimates, raises 2026 guidance…

Johnson & Johnson raises 2026 guidance as quarterly sales climb

Johnson & Johnson (NYSE:JNJ), the healthcare group, raised its 2026 sales and earnings forecasts after third-quarter sales grew 6% on…

MARKETS LIVE: US stocks trade mixed as chipmakers weigh on markets

11:35am: J&J, Dominos report Big banks werent the only sector reporting results on Tuesday. Johnson & Johnson (NYSE:JNJ) (Johnson &…

UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings?

Healthcare giants UnitedHealth Group and Johnson & Johnson reported Q3 results on Tuesday, with both raising their full-year earnings outlooks…

Deutsche Bank trims Johnson Service Group target to 200p on weak catering demand and rising energy costs

Deutsche Bank cut its price target on Johnson Service Group plc (LSE:JSG) to 200p from 210p, citing weaker trading among…

Why is Johnson Electric stock plunging today?

Why is Johnson Electric stock plunging today?…

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Brownsville Projects Carry $41.1 Billion in Estimated Investment

Four Cameron County projects carry a combined estimated investment of $41.1 billion, according to a county-branded graphic Dan Garcia, a…

Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?

Johnson & Johnson (JNJ) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…

Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?

JNJ trades at a 28% discount on valuation while LLYs cardiometabolic drugs drive 82% of revenue, each bet carries distinct…

BofA thinks Wall Street is underestimating one J&J drug

Bank of America nearly doubled its peak sales estimate for one Johnson & Johnson drug ahead of the companys third-quarter…

Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale

Johnson & Johnsons revenue base runs roughly double Bristol-Myers Squibbs, with the gap showing signs of widening over the past…

Jabil’s Double-Beat and Raise Is a Signal That This Rally Will Continue

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.…

3 Reasons Johnson & Johnson Is Still a Buy With Its Stock Near a Record High

This is not an exhaustive list.…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie bets on pipeline diversification amid patent cliffs, while J&Js higher profitability masks litigation risks, a choice between growth ambition…

Johnson Outdoors Announces Cash Dividend

RACINE, Wis., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…

Johnson & Johnson says Tremfya eases spinal pain in Phase 4 psoriatic arthritis study

Johnson & Johnson (NYSE:JNJ) said its Tremfya treatment significantly improved spinal pain and stiffness in adults with axial psoriatic arthritis…

Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldnt Miss What That Could Signal

Healthcare giant Johnson & Johnson is looking to become a more profitable and faster-growing business.…

Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight

The launch of emerging therapies such as ILUMYA/ILUMETRI (tildrakizumab-asmn; Sun Pharma), Izokibep (Affibody Medical), ICOTYDE (icotrokinra; Johnson & Johnson), Zasocitinib…

Johnson & Johnson (JNJ) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

…

Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Apollo Global in talks to acquire J&Js orthopedics unit, Bloomberg News reports

Apollo Global Management is ?in discussions to acquire Johnson & Johnsons orthopedics unit ?in a deal that could value the…

3 Top Dividend Aristocrats To Own Near All-Time Highs

Several Dividend Aristocrats, including Johnson & Johnson (JNJ), Coca-Cola (KO), and Exxon Mobil (XOM), are trading near all-time highs, reflecting…

Johnson & Johnson Aktie: Warum HSBC trotz hoher Bewertungen zum Kauf rät

London (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von HSBC:HSBC habe das Kursziel für die Aktie von Johnson & Johnson (J&J) (ISIN:…

Johnson & Johnson erhält CE-Kennzeichnung für wiederverwendbare Kontaktlinsen der Marke ACUVUE OASYS MAX

LIMERICK, Irland--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) gab heute bekannt, dass das Unternehmen die CE-Kennzeichnung für ACUVUE OASYS MAX 2-Week***…

Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Johnson & Johnson (JNJ) reached $269.12 at the closing of the latest trading day, reflecting a -2.22% change compared to…

4 Leisure & Recreation Stocks Worth Watching Despite Industry Pressure

Escalade, Malibu Boats, MasterCraft Boat and Johnson Outdoors show growth potential through innovation, brand strength and strategic expansion.…

Smart-Home Integration With Brilliant Might Change The Case For Investing In Johnson Controls (JCI)

On 3 September 2026, Brilliant NextGen Inc. announced a new integration that allows Johnson Controls’ IQ Panel 5 security system…

J&Js run to record highs hasnt reached the finish line yet. Here are the key drivers

Jim Cramer agrees with UBS: The rally in Johnson & Johnson shares still has room to run.…

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

Johnson & Johnson (JNJ) closed at $271.19 in the latest trading session, marking a +2.01% move from the prior day.…

AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.…

Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets.

Johnson & Johnson and Merck are healthcare giants with dependable returns that weather economic downturns well.…

Johnson & Johnson Just Got a Big FDA Win

The companys autoimmune drug was approved for the treatment of a rare blood disease.…

The Zacks Analyst Blog Highlights JPMorgan, Johnson & Johnson, Mastercard and Comstock

JPMorgan leads today???s featured research, with growth drivers, strategic moves and key risks highlighted across major stocks and a microcap.…

Johnson Supply Completes Rebrand as Johnson HVAC Distribution, Launches New Website and Refreshes All 25 Locations Across Texas and Louisiana

johnsonhvacdist.com goes live as the company steps fully into its next chapter johnsonhvacdist.com goes live as the company steps fully…

Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $270.27, denoting a -1.05% move from…